| |
| |
|
| Insider
Information: |
Bienaime Jean Jacques |
| Relationship: |
|
| City: |
Palo Alto |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
8 |
|
| Direct
Shares |
540,054 |
|
|
Indirect Shares
|
247,533 |
|
|
| Direct
Value |
$43,092,104 |
|
|
|
Indirect Value
|
$21,938,850 |
|
|
| Total
Shares |
787,587 |
|
|
| Total
Value |
$65,030,954 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
1
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
1
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
 -13.1%
|
-5.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2024-05-20 |
473,792 |
2024-05-20 |
247,533 |
Premium* |
|
|
Neurogesx Inc |
NGSX |
Director |
2011-07-26 |
21,748 |
|
0 |
Premium* |
|
|
InterMune Inc |
ITMN |
Director |
2014-09-29 |
0 |
2012-04-06 |
0 |
Premium* |
|
|
Portola Pharmaceuticals Inc |
PTLA |
Director |
2014-05-16 |
706 |
2013-05-28 |
0 |
Premium* |
|
|
Immunic Inc |
IMUX |
Director |
2018-09-24 |
18,500 |
2001-04-23 |
0 |
Premium* |
|
|
Incyte Corp |
INCY |
Director |
2023-06-14 |
15,493 |
|
0 |
Premium* |
|
|
Immunome Inc. |
IMNM |
|
2024-05-21 |
9,615 |
|
0 |
Premium* |
|
|
Keros Therapeutics, Inc. |
KROS |
|
2024-06-01 |
200 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
853 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 35
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| INCY |
Incyte Corp |
Director |
– • – |
2017-04-28 |
4 |
AB |
$124.26 |
$62,130 |
D/D |
500 |
3,677 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2008-02-29 |
4 |
S |
$37.91 |
$805,798 |
D/D |
(21,142) |
4,071 |
0 |
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2017-05-15 |
4 |
AB |
$115.00 |
$57,500 |
D/D |
500 |
4,177 |
0 |
- |
|
| ITMN |
InterMune Inc |
Director |
– • – |
2012-04-06 |
4 |
A |
$0.00 |
$0 |
D/D |
4,225 |
4,225 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2005-09-01 |
4 |
AB |
$8.58 |
$38,588 |
D/D |
4,500 |
4,500 |
2.81 |
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2017-05-31 |
4 |
AB |
$131.80 |
$65,900 |
D/D |
500 |
4,677 |
0 |
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2017-09-29 |
4 |
A |
$116.74 |
$14,476 |
D/D |
124 |
4,916 |
0 |
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2017-12-29 |
4 |
A |
$94.71 |
$14,491 |
D/D |
153 |
5,069 |
0 |
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2018-03-29 |
4 |
A |
$83.33 |
$14,499 |
D/D |
174 |
5,243 |
0 |
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2018-06-29 |
4 |
A |
$67.00 |
$14,472 |
D/D |
216 |
5,459 |
0 |
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2018-09-28 |
4 |
A |
$69.08 |
$14,438 |
D/D |
209 |
5,668 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2005-10-03 |
4 |
AB |
$8.51 |
$12,765 |
D/D |
1,500 |
6,000 |
2.81 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2008-04-30 |
4 |
AB |
$10.37 |
$21,248 |
D/D |
2,049 |
6,120 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2005-10-06 |
4 |
AB |
$8.00 |
$4,000 |
D/D |
500 |
6,500 |
2.73 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2005-10-12 |
4 |
AB |
$7.00 |
$3,500 |
D/D |
500 |
6,500 |
2.73 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2008-06-05 |
4 |
OE |
$6.46 |
$19,380 |
D/D |
3,000 |
6,567 |
0 |
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2018-11-08 |
4 |
B |
$68.62 |
$68,765 |
D/D |
1,000 |
6,668 |
2.39 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2007-08-03 |
4 |
AS |
$18.00 |
$36,053 |
D/D |
(2,000) |
6,695 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2007-08-10 |
4 |
S |
$20.20 |
$724,917 |
D/D |
(35,886) |
6,695 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2007-08-17 |
4 |
S |
$21.00 |
$210,000 |
D/D |
(10,000) |
6,695 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2007-09-19 |
4 |
AS |
$23.00 |
$230,000 |
D/D |
(10,000) |
6,695 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2007-09-25 |
4 |
AS |
$24.00 |
$240,000 |
D/D |
(10,000) |
6,695 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2007-10-01 |
4 |
AS |
$25.10 |
$19,904 |
D/D |
(793) |
6,695 |
0 |
- |
|
| ITMN |
InterMune Inc |
Director |
– • – |
2012-06-04 |
4 |
A |
$10.10 |
$25,250 |
D/D |
2,500 |
6,725 |
0 |
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2018-12-31 |
4 |
A |
$63.59 |
$14,499 |
D/D |
228 |
6,896 |
0 |
- |
|
853 Records found
|
|
Page 2 of 35 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
